Description
Gusacitinib is a dual inhibitor of SYK/JAK kinases.
| Product Unit Size | Cost | Quantity | Stock |
|---|
Gusacitinib is a dual inhibitor of SYK/JAK kinases.
| Cas No. | 1425381-60-7 |
|---|---|
| Purity | ≥98% |
| Formula | C24H28N8O2 |
| Formula Wt. | 460.54 |
| IUPAC Name | 2-[1-[4-[4-(4-hydroxypiperidin-1-yl)anilino]-5-oxo-6H-pyrimido[4,5-d]pyridazin-2-yl]piperidin-4-yl]acetonitrile |
| Synonym | ASN-002, ASN002 |
| Appearance | Yellow powder |
| Store Temp | -20°C |
|---|---|
| Ship Temp | Ambient |
| Info Sheet |
|---|
Montilla A, Gomez-Garcia F, Gomez-Arias P, et al. Scoping review on the use of drugs targeting JAK/STAT pathway in atopic dermatitis, vitiligo, and alopecia areata. Dermatol The (Heidelb). 2019 Dec;9(4):655-683. PMID: 31606872
Calcium channel blocker.
Endogenous peptide hormone fragment, involved i...
Red-orange terpene pigment found in various pla...
Geldanamycin derivative; HSP90 inhibitor.
Sulfur analog of furan found in cooked meat pro...
Paclitaxel derivative
EGFR inhibitor.
Synthesis impurity
Triazole; 14-α demethylase inhibitor, potentia...
Polymixin, antimicrobial peptide, induces forma...
Hexokinase inhibitor, aerobic glycolysis inhibi...
β-lactam; penicillin binding protein inhibitor...
Indirubin derivative.
σ1 antagonist.
Commercial food additive, antioxidant.
A probe for cholesterol in biological membranes...
Endogenous peptide hormone fragment, involved i...
Coccidiostat; dihydrofolate reductase inhibitor...
Found in Evodia rutaecarpa; potential cAMP, 3β...
Synthesis impurity